How is regadenoson (Lexiscan) administered as a pharmacologic stress agent for myocardial perfusion imaging in an adult patient without contraindications who has fasted for at least two hours and avoided caffeine for twelve hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Lexiscan (Regadenoson) is Performed

Lexiscan is administered as a fixed 0.4 mg dose (5 mL) given as a rapid intravenous bolus over 10 seconds, immediately followed by a 5 mL saline flush, with the radionuclide tracer injected 10-20 seconds after the saline flush. 1

Pre-Procedure Requirements

Patient Preparation:

  • Patients must avoid all methylxanthine products (caffeinated coffee, tea, caffeinated beverages, aminophylline, theophylline) for at least 12 hours before the procedure 1
  • Ensure at least 2 hours of fasting prior to imaging
  • Verify absence of contraindications: second- or third-degree AV block or sinus node dysfunction without a functioning pacemaker 1

Administration Protocol

Step-by-Step Procedure:

  1. IV Access: Establish peripheral IV access using a 22-gauge or larger catheter or needle (right arm preferable) 2

  2. Visual Inspection: Inspect the pre-filled syringe for particulate matter or discoloration; do not use if present 1

  3. Regadenoson Injection: Administer the entire 5 mL (0.4 mg) dose as a rapid IV bolus within 10 seconds 2, 1

    • This is a fixed dose with no weight-based adjustment required 2
    • The rapid injection timing is critical—longer injection times may increase the duration and magnitude of coronary blood flow 1
  4. Saline Flush: Immediately follow with a 5 mL saline flush 1

  5. Radionuclide Administration: Inject the radionuclide tracer 10-20 seconds after the saline flush 1

    • The tracer may be injected directly into the same catheter as Lexiscan
  6. Optimal Imaging Window: Acquire images 2-4 minutes after drug infusion 2

Monitoring and Safety

During and After Administration:

  • Cardiac resuscitation equipment and trained staff must be available before administering Lexiscan 1
  • Monitor vital signs: expect heart rate increase (mean increase ~24 bpm from baseline ~70 to ~95 bpm) and slight blood pressure decrease (systolic drops from ~129 to ~123 mmHg) 3
  • Most adverse effects begin soon after administration and resolve within approximately 15 minutes 4
  • Common transient effects include dyspnea (64.2%), headache (20-21%), sensation of warmth (20.2%) 3, 5

Key Advantages Over Other Vasodilators

Why This Protocol is Simpler:

  • No infusion pump required—administered by hand-held syringe unlike adenosine 2
  • Fixed bolus dose simplifies workflow compared to weight-based adenosine dosing 2
  • Rapid administration (10 seconds) versus 6-minute adenosine infusion 2
  • Can be used in patients with mild-to-moderate reactive airway disease, unlike adenosine 6, 3

Critical Pitfalls to Avoid

Common Errors:

  • Do not extend injection time beyond 10 seconds—this may prolong coronary hyperemia beyond the desired window 1
  • Do not skip the saline flush—ensures complete drug delivery
  • Do not use in patients with high-grade AV block without pacemaker—risk of asystole (0.03% incidence) 1, 3
  • Verify 12-hour caffeine abstinence—caffeine consumed 12-24 hours prior significantly attenuates the hemodynamic response (blunted heart rate and blood pressure rise) 7

Antidote Availability

Aminophylline should be immediately available to reverse serious reactions, though the short half-life of regadenoson (terminal half-life ~2 hours, with effects wearing off rapidly) means antidote is rarely needed 2, 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.